Smoking Cessation Author: Kumanan Wilson, MD
Editorial changes - 2010-02-17
Author information and module status
Key Points
Population at Risk
Effectiveness/Harms of Counseling or Intervention on Changing Behavior
Effectiveness/Harms of Behavior Change on Clinical Outcomes
Direct Effectiveness of Intervention/Counseling on Clinical Outcomes
Timeline
Cost-Effectiveness
Patient Education
Referral/Consultation
Guidelines
Tables
References
What's New
Patient Information
Additional Resources
Tools
Quality Measures Quality Measures
What's New
Alert
2009-07-01FDA MedWatch Safety Alert for Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics)

New Information
2009-07-22FDA and Public Health Experts Warn About Electronic Cigarettes
2009-07-01FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban

New Information from ACP
2010-02-02Annals of Internal Medicine Effectiveness of Extended-Duration Transdermal Nicotine Therapy
2010-01-05Annals of Internal Medicine Smoking, smoking cessation, and risk for type 2 diabetes mellitus
2010-02-01ACP Journal Club Estrogen plus progestin increased lung cancer mortality but not incidence in postmenopausal women

Newly Cited References
2007-02-01Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease.
2007-02-01The effect of a multi-component smoking cessation intervention in African American women residing in public housing.
2007-01-24Antidepressants for smoking cessation.
2007-01-24Family-based programmes for preventing smoking by children and adolescents.
2007-01-24Nicotine receptor partial agonists for smoking cessation.
2006-10-18Opioid antagonists for smoking cessation.
2006-10-18Tobacco cessation interventions for young people.
2006-10-01The effects of smoking cessation counseling by midwives on Dutch pregnant women and their partners.

New References of Interest
2010-01-21Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.
2010-01-05Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study.
2009-12-14Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics.
2009-12-03Forecasting the effects of obesity and smoking on U.S. life expectancy.
2009-11-01A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
2009-10-29Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study.
2009-10-01Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
FAQs
Edward Ellerbeck, MD, MPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Kumanan Wilson, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.